Chemotherapy of soft tissue sarcomas.
The medical treatment of advanced soft tissue sarcomas in adults is reviewed. Response rates of 40--50% are obtainable after various polychemotherapies, mainly containing doxorubicin and dacarbazine. Response to secondary treatment is very poor and indicates the need for further clinical research in these infrequent malignant tumors.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D012509:Sarcoma / Q000188:drug therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D003606:Dacarbazine; D004317:Doxorubicin